A low FODMAP (fermentable oligo-, di-, mono-saccharides and polyols) diet is often recommended in patients with quiescent inflammatory bowel disease (IBD) who experience irritable bowel syndrome-like symptoms. Concerns that the diet could exacerbate or re-activate inflammation by modifying microbiota fermentation and short-chain fatty acid (SCFA) production have been raised. Aims: This study examined the effect of altering dietary FODMAP content on inflammation and SCFA production in models of active and quiescent IBD. Methods: C57BL/6 mice were given 3% dextran sulfate sodium (DSS) in drinking water for 5-days and allowed to recover for 5-days (active-IBD model) or 3-weeks (post-inflammatory model). Following recovery, DSS-treated or control mice were randomized to a 2-week low FODMAP (0.51g/100g total FODMAP) or high FODMAP (4.10g/100g) diet. Diets mimicked human consumption and contained fructose, sorbitol, galacto-oligosaccharide and fructan. Colons were assessed for myeloperoxidase (MPO) activity, histological scores by blinded reviewers, and supernatants were collected for perforated patch-clamp recordings of dorsal root ganglion mouse neurons, a functional assay for proinflammatory cytokines. Cecum contents were analysed for SCFA (acetic, propionic, butyric, pentanoic acids) and branched-chain fatty acids (BCFA; isobutyric, isovaleric acids). Statistical analysis used one-way ANOVA with bonferroni. Results: Inflammatory markers were similar in mice receiving the low and high FODMAP diets within each treatment group (Fig 1A; MPO: low vs high FODMAP respectively, mean±SD, control 0.1±0.2vs0. 0±0.3, p>0.99; p>0.99; p>0.99. Histological scores: control 0±0vs0±0, p>0.99; p>0.99; postinflammatory 0.5±1vs0.3±0.5, p>0.99). In the post-inflammatory model, no difference in rheobase occurred during patch-clamp recordings (Fig 1B; 62.4±28.3vs64.9±20.8pA; p>0.99). No differences in cecal total SCFA content were seen between the diets. Differences in BCFA were seen with the low FODMAP diet
Background:
A low FODMAP (fermentable oligo-, di-, mono-saccharides and polyols) diet is often recommended in patients with quiescent inflammatory bowel disease (IBD) who experience irritable bowel syndrome-like symptoms. Concerns that the diet could exacerbate or re-activate inflammation by modifying microbiota fermentation and short-chain fatty acid (SCFA) production have been raised. Aims: This study examined the effect of altering dietary FODMAP content on inflammation and SCFA production in models of active and quiescent IBD. Methods: C57BL/6 mice were given 3% dextran sulfate sodium (DSS) in drinking water for 5-days and allowed to recover for 5-days (active-IBD model) or 3-weeks (post-inflammatory model). Following recovery, DSS-treated or control mice were randomized to a 2-week low FODMAP (0.51g/100g total FODMAP) or high FODMAP (4.10g/100g) diet. Diets mimicked human consumption and contained fructose, sorbitol, galacto-oligosaccharide and fructan. Colons were assessed for myeloperoxidase (MPO) activity, histological scores by blinded reviewers, and supernatants were collected for perforated patch-clamp recordings of dorsal root ganglion mouse neurons, a functional assay for proinflammatory cytokines. Cecum contents were analysed for SCFA (acetic, propionic, butyric, pentanoic acids) and branched-chain fatty acids (BCFA; isobutyric, isovaleric acids). Statistical analysis used one-way ANOVA with bonferroni. Results: Inflammatory markers were similar in mice receiving the low and high FODMAP diets within each treatment group ( Fig 1A; MPO: low vs high FODMAP respectively, mean±SD, control 0.1±0.2vs0.0±0.3, p>0.99; active-IBD 36.9±20.0vs34.9±17.0, p>0.99; post-inflammatory 1.6±2.2vs0. 6±0.9, p>0.99. Histological scores: control 0±0vs0±0, p>0.99; p>0.99; postinflammatory 0.5±1vs0.3±0.5, p>0.99) . In the post-inflammatory model, no difference in rheobase occurred during patch-clamp recordings (Fig 1B; 62.4±28.3vs64.9±20.8pA; p>0.99). No differences in cecal total SCFA content were seen between the diets. Differences in BCFA were seen with the low FODMAP diet in the active-IBD and post-inflammatory groups but not in the control group (control 0.2±0.0vs0.1±0.1nmol/mg, p=0.99; active-IBD 0.3±0.1vs0.2±0.0, p=0.00; postinflammatory 0.3±0.0vs0.1±0.0, p=0.00), suggesting proteolytic fermentation. Conclusions: A short-term low FODMAP diet shifts the microbiota toward more proteolytic fermentation. In this model, the low FODMAP diet does not seem to lead to exacerbation of overt inflammation.
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